2Mon·

Bavarian Nordic
$BAVA (-1.93%) plans to expand the production of its Mpox (monkeypox)-vaccine by the end of 2025 to ten million doses, with two million doses should already be available this year.

The WHO 🌎 has Mpox as a global health emergency.

Since January 2023, the Democratic Republic of Congo 🇨🇩 around 27,000 cases and over 1,100 deaths have been reported.

In Sweden 🇸🇪, the first case of a new Mpox variant outside Africa was recently confirmed.

attachment
5
3 Comments

profile image
Soon to be available again with bratwurst. Too bad Best Worscht isn't on the stock exchange. 😅
9
Wow, more than I expected! Money is being printed here!
1
The 2025 P/E ratio should therefore be in the single-digit range. My first price target here is +60 euros! I see hardly any risks for this scenario.
Join the conversation